Health care costs associated with chronic hepatitis B

American Journal of Health-System Pharmacy

Volumn 56, Issue 3, 1999, Pages 232-236

  Metcalf, Marilyn ^a   Brown, Nathaniel ^a   Peterson, Steven ^a   Feld, Andrew ^b   Gale, Fred ^c   Kirk, James ^c   Mabry, George ^c  

^a GLAXOSMITHKLINE   (United States)

^b CENTER FOR HEALTH STUDIES   (United States)

^c Eidetics   (United States)

Author keywords

Costs; Health care; Hepatitis B

Indexed keywords

ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DATA BASE; DIAGNOSTIC ACCURACY; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH MAINTENANCE ORGANIZATION; HEPATITIS B; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; PATIENT CARE; PRIORITY JOURNAL;

EID: 0033083249     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/56.3.232     Document Type: Article

References (3)

1. London TW, Evans AA. The epidemiology of hepatitis viruses B, C, and D. Clin Lab Med. 1996; 16:251-71.
2. Wong LL, McFall P, Wong MFL. The cost of dying of end-stage liver disease. Arch Intern Med. 1997; 157:1429-32.
3. Lok ASF, Van Leeuwen DJ, Thomas HC et al. Psychosocial impact of chronic infection with hepatitis B virus on British patients. Genitourin Med. 1985; 61:279-82.